Halozyme Therapeutics Inc (HALO) Institutional Ownership Tracker (Q2 2026)

HALO ranks #823 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

673 institutions disclose a position in HALO, but none treat it as a major bet — even Snyder Capital Management L P, its most concentrated holder, allocates just 3.2% of its own portfolio to it.

Congress Asset Management Co has added to its HALO position for two straight quarters, increasing it by $169.1M to reach $251.9M today.

HALO is down 1.3% today, but institutions show net buying of $1.2B this quarter — a divergence between today's price move and the underlying institutional flow.

HALO posted net income of $413.6M over the trailing twelve months, and currently trades at a P/E of 32.8.

• Profitable — net income of $413.6M over the trailing twelve months
• Revenue grew 41.2% year over year
• Net income declined year over year, from $557.3M to $413.6M
• Generated $651.6M in positive operating cash flow
• Current ratio of 4.66x — enough short-term assets to cover short-term liabilities
• Liabilities run 50.73x equity — a highly leveraged balance sheet worth noting